Shareholders' Equity And Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2026

Shareholders' Equity and Net Income Per Share Note [Abstract]

Schedule of Weighted Average Number of Shares

The following table illustrates earnings per share attributable to Versigent and the weighted average shares outstanding used in calculating basic and diluted earnings per share:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2026		2025		2026		2025
	(in millions, except per share data)
Numerator:




Net income attributable to Versigent	$	102	$	109	$	298	$	311




Denominator:
Weighted average ordinary shares outstanding, basic	70.85		70.89		70.88		70.89
Dilutive shares related to restricted stock units	1.40		—		0.79		—

Weighted average ordinary shares outstanding, including dilutive shares	72.25		70.89		71.67		70.89

Earnings per share attributable to Versigent:


Basic	$	1.44	$	1.54	$	4.20	$	4.39



Diluted	$	1.41	$	1.54	$	4.16	$	4.39

Schedule of Declared and Paid Cash Dividends Per Ordinary Share

The Company has declared and paid cash dividends per ordinary share during the periods presented as follows:


	Dividend Per Ordinary Share		Amount (in millions)
2026:
Third quarter	$	0.13	$	9
Total	$	0.13	$	9